Results 141 to 150 of about 33,352 (233)

Endothelin as a Treatment Target in Cardiovascular Diseases: A Recent Step Forward. [PDF]

Rev Cardiovasc Med
Cole A, Kiełbowski K, Dach A, Szulc J, Bakinowska E, Pawlik A.   +5 more
europepmc   +1 more source

An Explorative Approach to Examining the Role of Ischemia and Inflammation on the Function of Autoantibodies Against G Protein-Coupled Receptors and Their Corresponding Agonists. [PDF]

Int J Mol Sci
Wallukat G, Lakatos P, Steinhorst K, Flecks M, Hohberger B.   +4 more
europepmc   +1 more source

Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses. [PDF]

Front Pharmacol
Riemma MA, Madonna G, Mele E, Conte E, Telesca M, De Palma G, Kutryb-Zając B, Cicala C, Imbrici P, Liantonio A, De Angelis A, Urbanek K, Berrino L, Ialenti A, Cappetta D, Donniacuo M, Caiazzo E.   +16 more
europepmc   +1 more source

Endogenous mediators in regulating primary dysmenorrhea. [PDF]

Front Cell Dev Biol
Duan W, Ma Y, Dong Q, Wang Q, Xie Y, Liu G, Wang C, He M.   +7 more
europepmc   +1 more source

Activin A-Endothelin-1 Axis Governs Pulmonary Vascular Remodeling: Mechanistic Basis for Emerging Therapies in PAH. [PDF]

Arterioscler Thromb Vasc Biol
Faizah NN, Ryanto GRT, Kencana SMS, Suzuki Y, Hara T, Otake H, Emoto N.   +6 more
europepmc   +1 more source

The Influence of PAR 1 and Endothelin 1 on the Course of Specific Kidney Diseases. [PDF]

J Clin Med
Szymczak M, Żabińska M, Kościelska-Kasprzak K, Bartoszek D, Heidecke H, Schulze-Forster K, Janek Ł, Kujawa K, Wronowicz J, Marek-Bukowiec K, Gołębiowski T, Banasik M.   +11 more
europepmc   +1 more source

The Involvement of the Peptidergic Systems in Breast Cancer Development. [PDF]

Cancers (Basel)
Sánchez ML, Robinson P, Italia Z, Hoang T, Muñoz M, Coveñas R.   +5 more
europepmc   +1 more source

TERT expression in human prostate tissue reveals a potential molecular switch in benign prostatic hyperplasia progression. [PDF]

World J Urol
Xu Y, Hu S, Berger L, Nicola P, Weinhold P, Tamalunas A, Stief CG, Hennenberg M, Keller P.   +8 more
europepmc   +1 more source

Endogenous modulators in lung cancer. [PDF]

World J Clin Cases
Patel N, Patel V, Surani S.
europepmc   +1 more source

Disproportionality analysis of adverse events associated with endothelin receptor antagonists based on the FDA adverse event reporting system (FAERS). [PDF]

Front Cardiovasc Med
Han L, Li S, Liao J, Yin Q, He C, Wang Y, Li G, Bian Y.   +7 more
europepmc   +1 more source